Financial Comparison
Boston Scientific Corporation vs Zimmer Biomet Holdings, Inc.
Click a ticker to view the full analysis.
In short
Boston Scientific Corporation is the more profitable of the two, keeping 14.4% of revenue as net profit against 8.6% for Zimmer Biomet Holdings, Inc. Zimmer Biomet Holdings, Inc. trades at the higher trailing P/E (21.6× vs 17.0× for Boston Scientific Corporation), so investors pay more for each dollar of its earnings. Fisclear flags 1 medium- or high-severity risk for Boston Scientific Corporation and 0 for Zimmer Biomet Holdings, Inc.
Based on filings for periods ending 30 Jun 2026 (BSX) and 30 Jun 2026 (ZBH) · Updated
FisclearScore Comparison
FisclearScore is a quantitative model. BSX shown solid · ZBH shown dashed. Not financial advice.
| Metric | BSX | ZBH |
|---|---|---|
| Price | $42.04 | $88.88 |
| Market Cap | $60.9B | $17.0B |
| P/E (TTM) | 17.0x | 21.6x |
| P/B | 2.4x | 1.3x |
| Beta | 0.57 | 0.48 |
| Div Yield | 0.00% | 1.04% |
| Revenue (TTM) | $20.1B | $8.2B |
| Net Income | $2.9B | $705M |
| Gross Margin | 69.0% | — |
| Risk Flags | 1 flag | — |
Related comparisons
Data sourced from SEC EDGAR, Yahoo Finance, and official exchange filings. For informational purposes only. Not financial advice.